Integumen logo

SKIN - Integumen Share Price

1.43p -0.0  -0.9%

Last Trade - 8:53am

Sector
Healthcare
Size
Micro Cap
Market Cap £15.5m
Enterprise Value £14.8m
Revenue £567k
Position in Universe 1433rd / 1834
Bullish
Bearish
Unlock SKIN Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

SKIN Revenue Unlock SKIN Revenue

Net Income

SKIN Net Income Unlock SKIN Revenue

Normalised EPS

SKIN Normalised EPS Unlock SKIN Revenue

PE Ratio Range

SKIN PE Ratio Range Unlock SKIN Revenue

Dividend Yield Range

SKIN Dividend Yield Range Unlock SKIN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
SKIN EPS Forecasts Unlock SKIN Revenue
Profile Summary

Integumen plc is a United Kingdom-based personal health care company. The Company is engaged in developing and commercializing technology and products for the human integumentary system that may improve physical appearance, hygiene and general health outcomes. It is focused on commercializing technologies in the health and personal care products market, which are either on the market or at an advanced stage of product development. The skincare range intends to focus on anti-ageing and blemish control solutions, oral care for hygienic purposes and wound care for the diagnosis of chronic wounds. Its business is divided into four divisions, including skincare, oral care, wound care and three dimensional (3D) human skin equivalent. Its offerings in skincare division include Visible Youth and Clarogel; oral care division include TS1; wound care division include Wound pHase and Hydrogel, and 3D human skin equivalent include Labskin. Its subsidiaries include TSpro and Integumen Inc.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated May 28, 2016
Public Since April 5, 2017
No. of Shareholders: n/a
No. of Employees: 9
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 1,072,416,903
Free Float (0.0%)
Eligible for
ISAs
SIPPs
SKIN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for SKIN
Upcoming Events for SKIN
Thursday 30th July, 2020 Estimate
Integumen PLC Annual Shareholders Meeting
Similar to SKIN
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.